Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DTCFF Defence Therapeutics Inc (QB)

0.00 (0.00%)
Last Updated: 12:11:15
Delayed by 15 minutes

Defence Therapeutics (QB) Financial Summary

The current DTCFF market cap is 59.81M. The company's latest EPS is CAD -0.1527 and P/E is -8.84.

Year End June 29 2023 2020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 0000
Operating Income -179k-974k-2.97M-2.37M
Net Income -673k-2.86M-7.34M-6.76M
Year End June 29 2023 2020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 1.91M5.61M720k3.53M
Total Liabilities 48k122k1.11M1.97M
Total Equity 1.86M5.49M-388k1.57M

Cash Flow

Year End June 29 2023 2020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)
Operating -133k-2.29M-6.04M-7.66M
Investing -46k N/A N/A -66k
Financing 2.04M5.88M1.1M10.01M
Market Cap 59.81M
Price to Earnings Ratio -8.84
Price to Sales Ratio 0
Price to Cash Ratio 21.43
Price to Book Ratio 38.19
Dividend Yield -

Share Statistics

Shares Outstanding 44.3M
Average Volume (1 week) 333
Average Volume (1 Month) 240
52 Week Change -65.65%
52 Week High 4.47
52 Week Low 1.25
Spread (Intraday) 0.08 (5.63%)

Company Info

Company Name Defence Therapeutics Inc (QB)
Address 1680 – 200 burrard street
vancouver, british columbia V6C 3L6
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock